uniQure N.V.(QURE)- NASDAQ
From other sites
Company Description
uniQure NV engages in the discovery, development, and commercialization of gene therapies. Its core gene therapies include AMT-060 for the treatment of hemophilia B; preclinical S100A1 therapeutic for the treatment of congestive heart failure; and Glybera a gene therapy that is designed to... More
Sector: Healthcare
Industry: Drug Related Products
Country: Netherlands